These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 37572494)

  • 1. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes.
    Sadrabadi F; Alarcan J; Sprenger H; Braeuning A; Buhrke T
    Arch Toxicol; 2024 Feb; 98(2):507-524. PubMed ID: 38117326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
    Ojo AF; Xia Q; Peng C; Ng JC
    Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional effects of binary combinations of PFAS in FaO cells.
    Bjork JA; Dawson DA; Krogstad JO; Wallace KB
    Toxicology; 2021 Dec; 464():152997. PubMed ID: 34695511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
    Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
    Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells.
    Louisse J; Rijkers D; Stoopen G; Janssen A; Staats M; Hoogenboom R; Kersten S; Peijnenburg A
    Arch Toxicol; 2020 Sep; 94(9):3137-3155. PubMed ID: 32588087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.
    Roth K; Yang Z; Agarwal M; Liu W; Peng Z; Long Z; Birbeck J; Westrick J; Liu W; Petriello MC
    Environ Int; 2021 Dec; 157():106843. PubMed ID: 34479135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.
    Marques ES; Agudelo J; Kaye EM; Modaresi SMS; Pfohl M; Bečanová J; Wei W; Polunas M; Goedken M; Slitt AL
    Toxicology; 2021 Oct; 462():152921. PubMed ID: 34464680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress.
    Omoike OE; Pack RP; Mamudu HM; Liu Y; Strasser S; Zheng S; Okoro J; Wang L
    Environ Res; 2021 May; 196():110361. PubMed ID: 33131681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study.
    Averina M; Huber S; Almås B; Brox J; Jacobsen BK; Furberg AS; Grimnes G
    Environ Res; 2024 Feb; 242():117703. PubMed ID: 37984785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic re-analyses of human hepatocyte spheroids treated with PFAS reveals chain length and dose-dependent modes of action.
    Barutcu AR; Black MB; Andersen ME
    Toxicol Appl Pharmacol; 2024 Aug; 489():117013. PubMed ID: 38936668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Transcriptomic Analysis of Human Primary Hepatocyte Spheroids Exposed to Per- and Polyfluoroalkyl Substances as a Platform for Relative Potency Characterization.
    Rowan-Carroll A; Reardon A; Leingartner K; Gagné R; Williams A; Meier MJ; Kuo B; Bourdon-Lacombe J; Moffat I; Carrier R; Nong A; Lorusso L; Ferguson SS; Atlas E; Yauk C
    Toxicol Sci; 2021 May; 181(2):199-214. PubMed ID: 33772556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice.
    Attema B; Janssen AWF; Rijkers D; van Schothorst EM; Hooiveld GJEJ; Kersten S
    Mol Metab; 2022 Dec; 66():101602. PubMed ID: 36115532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Combined Per- and Polyfluoroalkyl Substances and Metals with Chronic Kidney Disease.
    Haruna I; Obeng-Gyasi E
    Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.